Drug Importation Plan to Lower Costs Announced by Trump Team (1)

Prescription medication approved in Canada or manufactured by drug makers who have products already approved by the FDA would get streamlined paths to U.S. markets under a new Trump administration plan.

The July 31 plan, released by the Department of Health and Human Services and the Food and Drug Administration, outlines two new policy proposals to import drugs to the U.S. that were originally intended for a foreign market. Importing drugs would expand on President Donald Trump’s goal to reduce the cost of medications for patients, the administration says.

“This is the next important step in the Administration’s work ...